ArticleBMC medical imaging2026
Identification of ischemic stroke risk in patients with left ventricular non-compaction using echocardiography, deep learning, and radiomics.
Article in BMC medical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundThere is a certain correlation between left ventricular non-compaction (LVNC) and ischemic stroke (IS); however, there are currently no predictive models available to assess the risk of IS in LVNC patients.
methodsA multicenter retrospective study included 309 LVNC patients from two institutions. Institution 1 (228 patients) provided a training and internal validation set, while institution 2 (81 patients) served as the external validation set. The deep transfer learning features were extracted using a ResNet101-based model, and the radiomics features were extracted using Pyradiomics. Feature selection was done with LASSO, the selected features were input into XGBoost to construct the Res101-RAD-XGB model. Model performance was evaluated using receiver operating characteristic (ROC) curves and decision curve analysis (DCA), and the model's interpretability was assessed using SHAP analysis and the Grad-CAM method. Finally, the performance of the Res101-RAD-XGB model was compared with that of clinical criteria to assess its effectiveness.
resultsThe Res101-RAD-XGB model achieved area under the curve (AUCs) of 0.942, 0.913, and 0.921 for the training, internal validation, and external validation sets, outperforming models using only one type of feature and clinical criteria.
conclusionThe Res101-RAD-XGB model can accurately identify LVNC patients who are at risk of IS, enabling specialists to develop targeted preventive strategies for high-risk individuals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.